p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer

Clinical trial NCT02275039 · COMPLETED

Trial details

NCT number: NCT02275039
Sponsor: City of Hope Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Ovarian Epithelial Cancer Recurrent Fallopian Tube Carcinoma Recurrent Primary Peritoneal Carcinoma

Start date: 2015-01-01
Primary completion: 2018-04-23
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.